Matthew Wood
Matthew Wood
Latest posts from :
Greater emphasis on a customer-centric approach in pharma fosters trust, value...
Certain medicines have been given a new type of status by the Food and Drug...
A paradigm shift in developing treatments for patients with Alzheimer’s...
A National Institute of Health study has found that a telltale boost of...
Matthew Wood talks to Rick Kates, Global Head of Viterion Telehealthcare, a...
After a storm of commotion in light of Merck & Co’s drug Tredaptive,...
Merck Sharp and Dohme, better known simply as Merck and Co., recently informed...
One of the greatest concerns encountered by the pharma industry worldwide is...
Personalized medication remains a hot topic in the pharma industry so it is...
More and more evidence has come to light that R&D in the pharma industry is...